circRNA basic information
circBase ID: hsa_circ_0074269
Name: -
Synonym: circ_0074269
Host Gene: -
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: cytoplasm; exosome
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0002974
MONDO name: cervical cancer
Disease details: cervical cancer
Disease DO ID:
4362
Disease MeSH ID:
-
Disease NCIt ID:
C9311
Disease ICD11 ID:
1256072522
Disease OMIM ID:
603956
Species: Human
Species details: Homo sapiens
Tissue specimen:

cervical cancer samples; DDP-resistant cervical cancer samples; DDP-sensitive cervical cancer samples; tumor tissues

Cell lines:

Ect1/E6E7; CaSki; HeLa; CaSki/DDP-R; HeLa/DDP-R

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: TUFT1, Ago2
Associated microRNA: miR-485-5p
Biological function: Promotes DDP resistance, cell proliferation, colony formation, migration, and tumor growth, and inhibits apoptosis in DDP-resistant cervical cancer.
Molecular mechanism: circ_0074269 acts as a ceRNA sponge for miR-485-5p, thereby upregulating TUFT1 expression and promoting DDP resistance; it can also be delivered via exosomes.
Biological pathway or process:

chemoresistance (promotes); drug resistance (promotes); proliferation (promotes); migration (promotes); apoptosis (inhibits); ceRNA regulation (other); other pathway/process (other)

Detected method:
Q
Validation methods:

RNase R Treatment; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; MTT; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Wound Healing Assay; Western Blot; TUNEL; IHC (Immunohistochemistry); In Vivo Animal Model; Bioinformatics Analysis

Clinical significance:

circ_0074269 is proposed as a potential treatment target for cervical cancer and is associated with DDP resistance.

Description:

Hsa_circ_0074269/circ_0074269 is upregulated in DDP-resistant cervical cancer samples, cells, and exosomes. It promotes cisplatin resistance, tumor growth, proliferation, and migration while suppressing apoptosis through a ceRNA mechanism involving miR-485-5p-mediated regulation of TUFT1. The study supports circ_0074269 as a potential therapeutic target for overcoming DDP resistance in cervical cancer.

Confidence score:

0.8175

Other information
Title:

Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer.

Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: 2022
PubMed ID: 35075616
Study type:

combined biological and clinical study

Data availability: TCGA CESC; supplementary material available at https:// doi. org/ 10. 1007/ s43032-022-00855-9
Code availability: -